Evaluation of the QuantiFERON-TB Test.
| Status: | Recruiting |
|---|---|
| Conditions: | Infectious Disease |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 4/5/2017 |
| Start Date: | May 2014 |
| End Date: | December 2017 |
| Contact: | Ashley Knights, Dr.rer.nat |
| Email: | Ashley.Knights@qiagen.com |
| Phone: | 301-944-7108 |
To compare the results of the investigational test to the currently approved QuantiFERON-TB
Gold In-Tube test.
Gold In-Tube test.
Inclusion Criteria:
- Clinical symptoms consistent with a high probability of having TB disease
- Receiving, or are likely to receive, therapy for active TB
- Confirmed tuberculosis by either AFB smear and culture testing, or Nucleic Acid
Amplification methods and culture testing.
- Between 18 and 70 years of age.
Exclusion Criteria:
- Taken therapy for active TB or latent TB for more than 14 days
- Culture confirmation of M. tuberculosis not obtained
We found this trial at
1
site
Los Angeles, California 90033
213) 740-2311
Principal Investigator: Brenda Jones, MD
Phone: 323-224-5014
University of Southern California The University of Southern California is one of the world’s leading...
Click here to add this to my saved trials
